CD274 and neoplasm: A GLP toxicology study performed by a third-party company to determine the safety and biodistribution of CF33-hNIS-anti-PD-L1 in tumor bearing C57BL/6 mice treated with single or multiple injections of the virus at various dose levels showed no virus-related toxicity.